|
1
|
Schmidt S and Debant A: Function and
regulation of the Rho guanine nucleotide exchange factor Trio.
Small GTPases. 5:e297692014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bellanger JM, Lazaro JB, Diriong S,
Fernandez A, Lamb N and Debant A: The two guanine nucleotide
exchange factor domains of Trio link the Rac1 and the RhoA pathways
in vivo. Oncogene. 16:147–152. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Steven R, Kubiseski TJ, Zheng H, Kulkarni
S, Mancillas J, Ruiz Morales A, Hogue CW, Pawson T and Culotti J:
UNC-73 activates the Rac GTPase and is required for cell and growth
cone migrations in C. elegans. Cell. 92:785–795. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Awasaki T, Saito M, Sone M, Suzuki E,
Sakai R, Ito K and Hama C: The Drosophila trio plays an essential
role in patterning of axons by regulating their directional
extension. Neuron. 26:119–131. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bateman J, Shu H and Van Vactor D: The
guanine nucleotide exchange factor trio mediates axonal development
in the Drosophila embryo. Neuron. 26:93–106. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liebl EC, Forsthoefel DJ, Franco LS,
Sample SH, Hess JE, Cowger JA, Chandler MP, Shupert AM and Seeger
MA: Dosage-sensitive, reciprocal genetic interactions between the
Abl tyrosine kinase and the putative GEF trio reveal trio's role in
axon pathfinding. Neuron. 26:107–118. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Newsome TP, Schmidt S, Dietzl G, Keleman
K, Asling B, Debant A and Dickson BJ: Trio combines with dock to
regulate Pak activity during photoreceptor axon pathfinding in
Drosophila. Cell. 101:283–294. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
O'Brien SP, Seipel K, Medley QG, Bronson
R, Segal R and Streuli M: Skeletal muscle deformity and neuronal
disorder in Trio exchange factor-deficient mouse embryos. Proc Natl
Acad Sci USA. 97:pp. 12074–12078. 2000; View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Charrasse S, Comunale F, Fortier M,
Portales-Casamar E, Debant A and Gauthier-Rouvière C: M-cadherin
activates Rac1 GTPase through the Rho-GEF trio during myoblast
fusion. Mol Biol Cell. 18:1734–1743. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
deBakker CD, Haney LB, Kinchen JM,
Grimsley C, Lu M, Klingele D, Hsu PK, Chou BK, Cheng LC, Blangy A,
et al: Phagocytosis of apoptotic cells is regulated by a
UNC-73/TRIO-MIG-2/RhoG signaling module and armadillo repeats of
CED-12/ELMO. Curr Biol. 14:2208–2216. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng M, Simon R, Mirlacher M, Maurer R,
Gasser T, Forster T, Diener PA, Mihatsch MJ, Sauter G and Schraml
P: TRIO amplification and abundant mRNA expression is associated
with invasive tumor growth and rapid tumor cell proliferation in
urinary bladder cancer. Am J Pathol. 165:63–69. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Adamowicz M, Radlwimmer B, Rieker RJ,
Mertens D, Schwarzbach M, Schraml P, Benner A, Lichter P,
Mechtersheimer G and Joos S: Frequent amplifications and abundant
expression of Trio, NKD2, and IRX2 in soft tissue sarcomas. Genes
Chromosomes Cancer. 45:829–838. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lane J, Martin TA, Mansel RE and Jiang WG:
The expression and prognostic value of the guanine nucleotide
exchange factors (GEFs) Trio, Vav1 and TIAM-1 in human breast
cancer. Int Semin Surg Oncol. 5:232008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Baldwin C, Garnis C, Zhang L, Rosin MP and
Lam WL: Multiple microalterations detected at high frequency in
oral cancer. Cancer Res. 65:7561–7567. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chattopadhyay I, Singh A, Phukan R,
Purkayastha J, Kataki A, Mahanta J, Saxena S and Kapur S:
Genome-wide analysis of chromosomal alterations in patients with
esophageal squamous cell carcinoma exposed to tobacco and betel
quid from high-risk area in India. Mutat Res. 696:130–138. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Coe BP, Henderson LJ, Garnis C, Tsao MS,
Gazdar AF, Minna J, Lam S, Macaulay C and Lam WL: High-resolution
chromosome arm 5p array CGH analysis of small cell lung carcinoma
cell lines. Genes Chromosomes Cancer. 42:308–313. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Salhia B, Tran NL, Chan A, Wolf A, Nakada
M, Rutka F, Ennis M, McDonough WS, Berens ME, Symons M, et al: The
guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate
the invasive behavior of glioblastoma. Am J Pathol. 173:1828–1838.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang B, Fang J, Qu L, Cao Z, Zhou J and
Deng B: Upregulated TRIO expression correlates with a malignant
phenotype in human hepatocellular carcinoma. Tumour Biol.
36:6901–6908. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sonoshita M, Itatani Y, Kakizaki F,
Sakimura K, Terashima T, Katsuyama Y, Sakai Y and Taketo MM:
Promotion of colorectal cancer invasion and metastasis through
activation of NOTCH-DAB1-ABL-RHOGEF protein TRIO. Cancer Discov.
5:198–211. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arbyn M, Castellsagué X, de Sanjosé S,
Bruni L, Saraiya M, Bray F and Ferlay J: Worldwide burden of
cervical cancer in 2008. Ann Oncol. 22:2675–2686. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang PP, Sun BC, Zhao JH, Chen KX, Lou YL
and Hao X: Changes in incidence rates of cervical cancer in a
geographically defined Chinese population and their implications in
screening and education programs. Ann Epidemiol. 15:630–631. 2005.
View Article : Google Scholar
|
|
22
|
Bray F, Loos AH, McCarron P, Weiderpass E,
Arbyn M, Møller H, Hakama M and Parkin DM: Trends in cervical
squamous cell carcinoma incidence in 13 European countries:
Changing risk and the effects of screening. Cancer Epidemiol
Biomarkers Prev. 14:677–686. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ward KK, Shah NR, Saenz CC, McHale MT,
Alvarez EA and Plaxe SC: Changing demographics of cervical cancer
in the United States (1973Y2008). Gynecol Oncol. 126:330–333. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qiu JT, Abdullah NA, Chou HH, Lin CT, Jung
SM, Wang CC, Chen MY, Huang KG, Chang TC and Lai CH: Outcomes and
prognosis of patients with recurrent cervical cancer after radical
hysterectomy. Gynecol Oncol. 127:472–477. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tong YQ, Liu B, Zheng HY, He YJ, Gu J, Li
F and Li Y: Overexpression of BMI-1 is associated with poor
prognosis in cervical cancer. Asia Pac J Clin Oncol. 8:e55–e62.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peng X, Wu Z, Yu L, Li J, Xu W, Chan HC,
Zhang Y and Hu L: Overexpression of cystic fibrosis transmembrane
conductance regulator (CFTR) is associated with human cervical
cancer malignancy, progression and prognosis. Gynecol Oncol.
125:470–476. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cibula D, Abu-Rustum NR, Dusek L, Slama J,
Zikán M, Zaal A, Sevcik L, Kenter G, Querleu D, Jach R, et al:
Bilateral ultrastaging of sentinel lymph node in cervical cancer:
Lowering the false-negative rate and improving the detection of
micrometastasis. Gynecol Oncol. 127:462–466. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Choi EJ, Kim MS, Yoo NJ and Lee SH: TRIO
gene encoding Trio Rho guanine nucleotide exchange factor harbors
frameshift mutations of in gastric and colorectal cancers. Pathol
Oncol Res. Feb 21–2017.(Epub ahead of print). View Article : Google Scholar
|
|
29
|
Pecorelli S: Revised FIGO staging for
carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol
Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ma DM, Xu YP and Zhu L: Expression of
vascular endothelial growth factor C correlates with a poor
prognosis based on analysis of prognostic factors in patients with
cervical carcinomas. J Obstet Gynaecol Res. 37:1519–1524. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shen MX and Ding JB: Expression levels and
roles of EMC-6, Beclin1, and Rab5a in the cervical cancer. Eur Rev
Med Pharmacol Sci. 21:3038–3046. 2017.PubMed/NCBI
|
|
32
|
Song Z, Zhang X, Ye X, Feng C, Yang G, Lu
Y, Lin Y and Dong C: High expression of stromal cell-derived factor
1 (SDF-1) and NF-κB predicts poor prognosis in cervical cancer. Med
Sci Monit. 23:151–157. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Olson MF and Sahai E: The actin
cytoskeleton in cancer cell motility. Clin Exp Metastasis.
26:273–287. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ridley AJ: Rho GTPases and cell migration.
J Cell Sci. 114:2713–2722. 2001.PubMed/NCBI
|
|
36
|
Ridley AJ: Rho family proteins:
Coordinating cell responses. Trends Cell Biol. 11:471–477. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Matsui T, Amano M, Yamamoto T, Chihara K,
Nakafuku M, Ito M, Nakano T, Okawa K, Iwamatsu A and Kaibuchi K:
Rho-associated kinase, a novel serine/threonine kinase, as a
putative target for small GTP binding protein Rho. EMBO J.
15:2208–2216. 1996.PubMed/NCBI
|
|
38
|
Kosako H, Yoshida T, Matsumura F, Ishizaki
T, Narumiya S and Inagaki M: Rho-kinase/ROCK is involved in
cytokinesis through the phosphorylation of myosin light chain and
not ezrin/radixin/moesin proteins at the cleavage furrow. Oncogene.
19:6059–6064. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bourguignon LY, Zhu H, Shao L, Zhu D and
Chen YW: Rho-kinase (ROK) promotes CD44v (3,8–10)-ankyrin
interaction and tumor cell migration in metastatic breast cancer
cells. Cell Motil Cytoskeleton. 43:269–287. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Itoh K, Yoshioka K, Akedo H, Uehata M,
Ishizaki T and Narumiya S: An essential part for Rho-associated
kinase in the transcellular invasion of tumor cells. Nat Med.
5:221–225. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li B, Zhao WD, Tan ZM, Fang WG, Zhu L and
Chen YH: Involvement of Rho/ROCK signalling in small cell lung
cancer migration through human brain microvascular endothelial
cells. FEBS Lett. 580:4252–4260. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Maekawa M, Ishizaki T, Boku S, Watanabe N,
Fujita A, Iwamatsu A, Obinata T, Ohashi K, Mizuno K and Narumiya S:
Signaling from Rho to the actin cytoskeleton through protein
kinases ROCK and LIM-kinase. Science. 285:895–898. 1999. View Article : Google Scholar : PubMed/NCBI
|
